Bio-Connect
Human IL-2 PicoKine ELISA Kit standard curve
Human IL-2 PicoKine ELISA Kit standard curve
Human IL-2 PicoKine ELISA Kit standard curve

Human IL-2/Interleukin-2 ELISA Kit PicoKine(r)

EK0397
Boster Bio
Product group Assays
96 wells
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Boster Bio
  • Product Name
    Human IL-2 PicoKine ELISA Kit
  • Delivery Days Customer
    9
  • Applications
    ELISA
  • Applications Supplier
    ELI
  • Assay Detection Range
    15.6 pg/ml - 1,000 pg/ml
  • Assay Sensitivity
    <1 pg/ml
  • Assay Time
    15-20
  • Certification
    Research Use Only
  • Scientific Description
    Human IL-2/Interleukin-2 ELISA Kit PicoKine® (96 Tests). Quantitate Human IL2 in cell culture supernatants, serum and plasma ( heparin, EDTA, citrate). Sensitivity: 1pg/ml. The brand Picokine indicates this is a premium quality ELISA kit. Each Picokine kit delivers precise quantification, high sensitivity, and excellent reproducibility. Only our most reliable and effective kits qualify as Picokine, guaranteeing top-tier results for your assays.
  • Reactivity Supplier
    Human IL-2
  • Storage Instruction
    -20°C,2°C to 8°C
  • UNSPSC
    41116158

References

  • Sarmin N, Roknuzzaman ASM, Sarker R, et al. Association of interleukin-2 and interleukin-10 with the pathophysiology and development of generalized anxiety disorder: a case-control study. BMC Psychiatry. 2024,24(1):462. doi: 10.1186/s12888-024-05911-z
    Read this paper
  • Wang C, Zhang H, Liu T, et al. Circulating Tfr/Tfh cell imbalance may contribute to the immunopathogenesis of pemphigus. J Eur Acad Dermatol Venereol. 2023,37(12):e1399-e1402. doi: 10.1111/jdv.19338
    Read this paper
  • Banerjee T, Rai S, Singh A, et al. Poor Glycemic Control Is Associated With Lower Interleukin-2 (IL-2) Levels and Low Macrophage Viability in Chronic Diabetic Foot Ulcers (DFUs). Int J Low Extrem Wounds. 2023,:15347346231182793. doi: 10.1177/15347346231182793
    Read this paper
  • Chen X, Wang S, Chen Y, et al. Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours. Nat Nanotechnol. 2023,18(8):933-944. doi: 10.1038/s41565-023-01378-3
    Read this paper
  • Xu J, Yang G, An W, et al. Correlations between the severity of radiation-induced oral mucositis and salivary epidermal growth factor as well as inflammatory cytokines in patients with head and neck cancer. Head Neck. 2023,45(5):1122-1129. doi: 10.1002/hed.27313
    Read this paper
  • Zhang Y, Yang S, Jiang D, et al. Screening and identification of an anti-PD-1 nanobody with antitumor activity. Biosci Rep. 2022,43(1). doi: 10.1042/BSR20221546
    Read this paper
  • Cheng L, Zhou S, et al. Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian Cancer. Cancer Res. 2022,82(19):3588-3602. doi: 10.1158/0008-5472.CAN-22-0222
    Read this paper
  • Wang J, Ge J, Wang Y, et al. EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun. 2022,13(1):866. doi: 10.1038/s41467-022-28479-2
    Read this paper
  • Kozachok S, Kolodziejczyk-Czepas J, Marchyshyn S, et al. Comparison of Phenolic Metabolites in Purified Extracts of Three Wild-Growing Herniaria L. Species and Their Antioxidant and Anti-Inflammatory Activities In Vitro. Molecules. 2022,27(2). doi: 10.3390/molecules27020530
    Read this paper
  • Liu Y, Li C, Yang Y, et al. The TGF-β/miR-31/CEACAM1-S axis inhibits CD4(+) CD25(+) Treg differentiation in systemic lupus erythematosus. Immunol Cell Biol. 2021,99(7):697-710. doi: 10.1111/imcb.12449
    Read this paper